BRIEF published on 03/25/2024 at 15:27, 7 months 28 days ago Vanguard Group Increases Stake in Ageas SA/NV Vanguard Group Shareholding Stock Transactions Ageas SA/NV Financial Investments
PRESS RELEASE published on 03/25/2024 at 15:22, 7 months 28 days ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.46% stake in Ageas SA/NV as of 22 March 2024. Additional disclosures related to Direct Line Insurance Group plc and recent securities transactions are provided in Form 8.3 Securities Transactions The Vanguard Group, Inc. Disclosure Ageas SA/NV
BRIEF published on 03/22/2024 at 15:26, 8 months ago Vanguard Reports Stake in Ageas SA/NV Securities Disclosure Vanguard Group Financial Markets Ageas SA/NV Insurance Sector Investment
PRESS RELEASE published on 03/22/2024 at 15:21, 8 months ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses 3.46% ownership in Ageas SA/NV as of 21 March 2024. Also making disclosures related to Direct Line Insurance Group plc Disclosure Vanguard Group Inc. Ownership Ageas SA/NV Direct Line Insurance Group Plc
BRIEF published on 03/21/2024 at 15:11, 8 months 1 day ago Vanguard Group Discloses Stake in Ageas SA/NV Securities Disclosure Vanguard Group Financial Markets Ageas SA/NV Investment Holding
PRESS RELEASE published on 03/21/2024 at 15:06, 8 months 1 day ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.46% stake in Ageas SA/NV as of 20 March 2024. Details include securities holdings and recent transactions Financial Transactions The Vanguard Group, Inc. Form 8.3 Disclosure Ageas SA/NV Securities Holdings
BRIEF published on 03/20/2024 at 14:27, 8 months 2 days ago Vanguard Increases Stake in Ageas SA/NV Vanguard Group Financial Markets Share Ownership Ageas SA/NV Insurance Sector
PRESS RELEASE published on 03/20/2024 at 14:22, 8 months 2 days ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses 3.46% stake in Ageas SA/NV. Disclosure made under Rule 8.3 of the Takeover Code. Additional disclosures made for Direct Line Insurance Group plc Disclosure Rule 8.3 Takeover Code The Vanguard Group Inc. Ageas SA/NV
BRIEF published on 03/19/2024 at 15:28, 8 months 3 days ago The Vanguard Group, Inc. Reports Shareholding in Ageas SA/NV Form 8.3 The Vanguard Group Financial Disclosure Shareholding Ageas SA/NV
PRESS RELEASE published on 03/19/2024 at 15:23, 8 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Ageas SA/NV The Vanguard Group, Inc. discloses a 3.46% interest in Ageas SA/NV under Form 8.3. Additional disclosures include Direct Line Insurance Group plc Form 8.3 Disclosure Vanguard Group Inc. Ageas SA/NV Direct Line Insurance Group
Published on 11/22/2024 at 23:55, 9 hours 11 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 36 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 1 minute ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 36 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 51 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 12 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 10 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 6 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
